Meditation for Psychological Distress in Breast Cancer Survivors
Trial Summary
What is the purpose of this trial?
Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a compassion meditation intervention called CBCT (Cognitively-Based Compassion Training) for online synchronous delivery that is also inclusive of informal caregivers (i.e., adult family members who live with and typically provide half the care for survivors, aka supportive partners).
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that participants can continue hormonal therapies or trastuzumab.
What data supports the effectiveness of the treatment Cognitively-Based Compassion Training for Dyads in breast cancer survivors?
Research suggests that Cognitively-Based Compassion Training (CBCT) can improve psychological well-being and reduce distress in breast cancer survivors, as well as in other populations. Studies have shown that CBCT may help reduce depressive symptoms and anxiety, and improve overall quality of life.12345
Is Cognitively-Based Compassion Training (CBCT) safe for breast cancer survivors?
How is Cognitively-Based Compassion Training (CBCT) different from other treatments for psychological distress in breast cancer survivors?
Cognitively-Based Compassion Training (CBCT) is unique because it focuses on enhancing self-compassion and reducing stress through meditation, which can help lower anxiety and depression by addressing worry and rumination. Unlike traditional treatments, CBCT specifically targets emotional regulation and self-kindness, offering a novel approach to improving psychological well-being in breast cancer survivors.23678
Research Team
Thaddeus Pace, PhD
Principal Investigator
University of Arizona
Eligibility Criteria
This trial is for English-speaking women who have finished their main breast cancer treatments (except hormonal therapies or trastuzumab) 3-5 years ago and are experiencing depression or anxiety. They must have a supportive partner to join them in the study. Women with regular meditation experience in the last 4 years or living in nursing homes cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CBCT-S, CBCT-D, or Health Education over 8 weeks
Follow-up
Participants are monitored for changes in depression and anxiety features
Treatment Details
Interventions
- Cognitively-Based Compassion Training for Dyads
- Cognitively-Based Compassion Training for Survivors
- Health Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
National Cancer Institute (NCI)
Collaborator